Print this page    •   Back to Web version of article

International News
China: AIDS Patient Receives Compensation

January 28, 2013

The education bureau of Jinxian County, China, agreed to pay a former teaching applicant 45,000 yuan ($7,228) in damages because the bureau allegedly turned him down after a pre-employment health check found he was HIV-infected. The settlement represents the first time an HIV-infected Chinese citizen has received compensation in an HIV employment discrimination suit, according to Cheng Yuan, director of the non-governmental organization (NGO) Tianxiogong. The NGO targets discrimination against people with hepatitis, HIV/AIDS, and disabilities.

Xiao Qi (pseudonym) initiated the milestone anti-discrimination suit against the education bureau in November 2012, and the parties reached agreement December 27 in local court mediation. In exchange for the payment, Xiao Qi agreed to drop discrimination charges against the education bureau.

China's 2006 Regulations on HIV/AIDS Prevention and Treatment protect the marriage, employment, medical treatment, and education rights of HIV-infected people and their relatives. According to China's Ministry of Health, there were 492,191 reported cases of HIV among the country's 1.3 billion people in October 2012, and an estimated total of 780,000 HIV-infected people in China.

Back to other news for January 2013

Excerpted from:
China Daily (Beijing)

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.